CompletedPHASE2, PHASE3NCT00919815
Ciclosporin in the Management of New Type 1 Reactions in Leprosy
Studying Leprosy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- London School of Hygiene and Tropical Medicine
- Principal Investigator
- Diana Lockwood, MBChBLondon School of Hygiene and Tropical Medicine
- Intervention
- Ciclosporin(drug)
- Enrollment
- 73 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2010 – 2013
Study locations (1)
- Alert Hospital, Addis Ababa, Ethiopia
Collaborators
Homes and Hospitals of St Giles · Alert Hospital, Ethiopia · Armauer Hansen Research Institute, Ethiopia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00919815 on ClinicalTrials.govOther trials for Leprosy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06761469Leprosy Active Searching Trial in BrazilHospital Alemão Oswaldo Cruz
- RECRUITINGNANCT06819449Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy PatientsSouth Valley University
- RECRUITINGNCT06683690TGF β 1 Expression Related Gene PolymorphismAswan University
- RECRUITINGPHASE3NCT05597280Bedaquiline Enhanced Post ExpOsure Prophylaxis for LeprosyInstitute of Tropical Medicine, Belgium
- RECRUITINGPHASE2NCT05243654Efficacy and Tolerability of Adjunct Metformin for Multibacillary LeprosyOxford University Clinical Research Unit Indonesia
- RECRUITINGNANCT06222372Novel Interventions and Diagnostic Tests for LeprosyAnnemieke Geluk